Key Drivers
- High margins
- Low leverage
- Rich multiples
AIAI Summary
ISRG's shift to a higher-recurring-revenue model driven by da Vinci V upgrades and My Intuitive+ makes its long-term value depend more on sustained upgrade cadence, subscription monetization, and margin recovery than on one-off system placements, so investors should hold/watch and require clear evidence of accelerating recurring revenue, improving margins, or meaningful subscription take-rates before increasing exposure.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High margins
- •Low leverage
- •Rich multiples
Intuitive Surgical is a high‑margin, cash‑generative, low‑leverage company with strong returns and liquidity but is priced at richly stretched multiples and dependent on continued execution given sizable recurring R&D/SG&A and capex.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •Bounced mid‑March
- •Lower highs persisting
ISRG is trading below its last-month SMA after failing to sustain late‑February highs and is bouncing off a mid‑March support (2026-03-13) with weak RSI, so reclaiming the last‑month SMA is needed to confirm a reversal or else the 3/13 support break risks further downside.
Momentum shifted sharply from late‑February highs into a mid‑March selloff, creating a clear resistance band
Sentiment & News
Key News Insights:
- •Product momentum
- •Geographic expansion
- •Valuation risk
Intuitive Surgical remains the robotic-surgery market leader with durable recurring-revenue engines and geographic/channel expansion (da Vinci 5, Ion, ASC push) supporting upside despite valuation concerns and near-term technical volatility.
The mix of strong procedural growth and new revenue initiatives should sustain long-term upside, though elevated multiples and short-term price swings increase near-term downside risk
Similar Companies in Healthcare
Other companies in the same sector with AI ratings